{
  "query": "recent COVID-19 news and developments in South India 2023-2024",
  "result": "answer='Recent COVID-19 developments in South India (2023-2024) include:\\n\\n- A rise in COVID-19 cases has been observed, particularly in Kerala, Tamil Nadu, and Karnataka.\\n- New variants such as JN.1 (a descendant of Omicron BA.2.86) and sub-variants NB.1.8.1 and LF.7 have been detected and are under observation for increased transmissibility.\\n- Hospitals follow revised treatment guidelines for COVID-19 and influenza symptoms.\\n- Vaccination efforts continue, with updated vaccines targeting new variants showing effectiveness.\\n- Authorities urge vigilance but state the situation is under control, with precautionary advisories issued.\\n- Active cases remain relatively low compared to earlier waves, with mild symptoms reported in most new cases.\\n\\nThese points summarize the recent COVID-19 situation and responses in South India based on the latest available information.' sources=[LinkupSource(name='Home | Ministry of Health and Family Welfare | GOI', url='https://mohfw.gov.in/', snippet='MInistry of Health and Family Welfare is a Ministry under the Government of India and is charged with formulation, implementatio\\nNew specified Health warning published via notification G.S.R. 742(E) dated 02nd December 2024 ... Requirement of polio vaccination for International travellers between India and polio infected countries. O.M. No. W -11037 / 40/2O22-Grants(RD)( Part2) dated 18/01/2023 regarding inclusion of 06 Rare Diseases with categorization under Para 6.2 of National Policy for Rare Diseases (NPRD), 2021'), LinkupSource(name='COVID-19 - Global Situation', url='https://www.who.int/emergencies/disease-outbreak-news/item/2025-DON572', snippet='Since mid-February 2025, according to data available from sentinel sites, global SARS-CoV-2 activity has been increasing, with the test positivity rate reaching 11%, levels that have not been observed since July 2024. This rise is primarily observed in countries in the Eastern Mediterranean, ...\\nSince mid-February 2025, according to data available from sentinel sites, global SARS-CoV-2 activity has been increasing, with the test positivity rate reaching 11%, levels that have not been observed since July 2024. This rise is primarily observed in countries in the Eastern Mediterranean, South-East Asia, and Western Pacific regions.\\nWHO continues to support Member States by convening and coordinating global stakeholders and relevant networks, developing evidence-based guidance and policy recommendations, and providing tailored support to assist Member States in building and sustaining core capabilities, in collaboration with other key partners. As per the latest WHO global risk assessment, covering the period July-December 2024, the global public health risk associated with COVID-19 remains high. There has been evidence of decreasing impact on human health throughout 2023 and 2024 compared to 2020-2023, driven mainly by:\\nFigure 5. SARS-CoV-2 tested specimens reported from sentinel sites to eGISRS from countries, areas and territories in the Western Pacific Region for 2024 and 2025* *Most recent week’s data may be incomplete. Source: Global Influenza Programme · Since the formal ending of the public health emergency of international concern (PHEIC) in May 2023, Member States have adopted diverse approaches to sustaining COVID-19 and broader coronavirus disease threat management.\\nInstitutionalize national and subnational coordination mechanisms, including those developed during the acute phase of the pandemic, into long-term respiratory disease threat management systems, aligned with a One Health approach. WHO further reminds Member States that the International Health Regulations (IHR) Standing Recommendations on COVID-19, issued by the Director-General following the expiration of the PHEIC in May 2023, remain valid through 30 April 2026.'), LinkupSource(name='COVID-19 cases | WHO COVID-19 dashboard', url='https://data.who.int/dashboards/covid19/cases', snippet=\"In addition, countries differ in ... a week in their reporting. As of 25 August 2023, WHO declared that it is no longer necessary for Member States to report daily counts of cases and deaths to WHO and requested strengthening of weekly reporting....\\nIn the context of WHO's statistical reporting of COVID-19 data, it is important to note that only confirmed cases are included in case and death counts. In guidance updated on 22 July 2023; there are two alternative definitions for 'Confirmed case of SARS-CoV-2 infection' in international surveillance reporting, although some departures may exist due to local adaptations:\\nIn addition, countries differ in how they choose to report statistics; some countries provide their data attributed to specific dates while others who report less frequently may group data from 7 days into a single statistic attributed to a week in their reporting. As of 25 August 2023, WHO declared that it is no longer necessary for Member States to report daily counts of cases and deaths to WHO and requested strengthening of weekly reporting.\"), LinkupSource(name='#IndiaFightsCorona COVID-19 in India, Vaccination, Dashboard , Corona Virus Tracker | mygov.in', url='https://www.mygov.in/covid-19/', snippet='Government of India is taking all necessary steps to ensure that we are prepared well to face the challenge and threat posed by the growing pandemic of COVID-19 the Corona Virus. Learn about Symptoms, Prevention, Travel Advisory and common FAQs on CoronaVirus.\\nGuidelines for International Arrivals (updated on 19th July 2023) - Source : mohfw.gov.in (PDF-121 byte) 19-07-2023\\nClinical Guidance for Management of Adult COVID-19 Patients - Source: mohfw.gov.in (PDF-121 byte) 28-03-2023\\nGuidelines for International Arrivals (updated on 10th February 2023) - Source: mohfw.gov.in (PDF-121 byte) 10-02-2023'), LinkupSource(name='Covid19 Dashboard | Home', url='https://covid19dashboard.mohfw.gov.in/', snippet='Notification · Resources · Awareness · District-wise COVID-19 test positivity rates · India · हिन्दी · Screen Reader Acess · A+ A A- · Ministry of Health and Family Welfare · Government of India\\nundefined'), LinkupSource(name='Covid 19 India Outbreak 2025 - Corona Virus Active Cases In India', url='https://www.covid19india.org/', snippet='Covid Cases are rising in India as of June 2025, according to various news around 4866 Active cases are there in india. Covid19india.org is providing data\\nPrime Minister Modi called a meeting on 22nd March 2023, to discuss the country’s readiness for a potential new wave of infections caused by the SARS-CoV-2 strain XBB.1.16.\\nAyushman Bharat Card Registration 2024 – ABHA Card Apply Online @ pmjay.gov.in'), LinkupSource(name='COVID-19 pandemic in India - Wikipedia', url='https://en.wikipedia.org/wiki/COVID-19_pandemic_in_India', snippet='This potential off-label prescription ... of patients with ivermectin. In January 2023, hydroxychloroquine and ivermectin were not recommended anymore at all in the national clinical guidance for management of adult covid-19 patients....\\nOn 24 March, Mylab Discovery Solutions became the first Indian company to have received regulatory validation for its RT-PCR tests. In April, Institute of Genomics and Integrative Biology, Delhi had developed a low cost paper-strip test that could detect COVID-19 within an hour. Each test would cost ₹500.00 (equivalent to ₹590 or US$7.00 in 2023).\\nThe 2021 budget of India also allocated ₹35,000 crore (equivalent to ₹410 billion or US$4.9 billion in 2023) for vaccine procurement. In January 2021, the DCGI initially approved the Oxford–AstraZeneca vaccine, manufactured by the Serum Institute of India (SII) under the trade name \"Covishield\", and BBV152 (Covaxin), a vaccine developed by Bharat Biotech in association with the Indian Council of Medical Research and National Institute of Virology.\\nThe Indian government infused ₹900 crore (equivalent to ₹11 billion or US$130 million in 2023) into the Department of Biotechnology in November 2020 to aid the development of a COVID vaccine.\\nThis potential off-label prescription seems to have taken off in some parts of India: Kavery Nambisan, an Indian surgeon, said that a doctor in Kandivali, Mumbai, has treated thousands of patients with ivermectin. In January 2023, hydroxychloroquine and ivermectin were not recommended anymore at all in the national clinical guidance for management of adult covid-19 patients.\\nOn 19 March 2020, Kerala announced a stimulus package of ₹20,000 crore (equivalent to ₹240 billion or US$2.8 billion in 2023) to help the state overcome both the COVID-19 epidemic and economic hardship caused by it. On 21 March, Uttar Pradesh announced ₹1,000 (equivalent to ₹1,200 or US$14 in 2023) to all daily wage labourers.'), LinkupSource(name='Coronavirus cases in India and World Live: Covid-19 India tracker live, State wise corona cases in India and World', url='https://timesofindia.indiatimes.com/coronavirus', snippet='The outbreak of coronavirus infection soon spread to other provinces of the country, forcing the govt to lockdown dozen of cities with millions of people. Within weeks, the coronavirus spread outside of the country to other nations like South Korea, Iran, Italy, United States, India, Pakistan ...\\nThe outbreak of coronavirus infection soon spread to other provinces of the country, forcing the govt to lockdown dozen of cities with millions of people. Within weeks, the coronavirus spread outside of the country to other nations like South Korea, Iran, Italy, United States, India, Pakistan among others.'), LinkupSource(name='COVID-19’s Return: New Variants, Mild Symptoms, and the Gaps in India’s Public Health Preparedness - Frontline', url='https://frontline.thehindu.com/news/covid19-surge-india-2025-jn1-variants-preparedness-vulnerable-groups/article69674310.ece', snippet='Hospitals have been directed to follow the revised ABC Guidelines 03, issued in June 2023, for treating patients with COVID-19 and influenza symptoms. All patients with symptoms of ILI (Influenza-Like Illness), ARI (Acute Respiratory Infection), or SARI (Severe Acute Respiratory Infection) ...\\nA 2024 Eurosurveillance study published in The Lancet estimated that the XBB.1.5 vaccine—a precursor to JN.1-targeted versions—had a vaccine effectiveness of 41 per cent in adults aged 18–59 and 50 per cent in those aged 60–85 against JN.1 infection. Also Read | COVID-19 rates are rising again—what you need to know · Dr. Swaminathan urged long-term investment in vaccine development.\\nOn May 28, 2025, the World Health Organization (WHO) reported a global increase in SARS-CoV-2 activity based on its Global Influenza Surveillance and Response System. Test positivity rates have risen steadily since mid-February, reaching 11 per cent—levels not observed since July 2024.\\nA 2024 study in Nature found that vaccines updated to target JN.1 or related sublineages such as KP.2 elicit robust neutralising antibody responses against JN.1 and its descendants, including KP.3.1.1, XEC, LF.7.2.1, and LP.8.1.\\nHospitals have been directed to follow the revised ABC Guidelines 03, issued in June 2023, for treating patients with COVID-19 and influenza symptoms. All patients with symptoms of ILI (Influenza-Like Illness), ARI (Acute Respiratory Infection), or SARI (Severe Acute Respiratory Infection) must be tested.'), LinkupSource(name='India sees gradual rise in Covid-19 cases, authorities urge caution but say situation under control | India News - Times of India', url='https://timesofindia.indiatimes.com/india/india-sees-gradual-rise-in-covid-19-cases-authorities-urge-caution-but-say-situation-under-control/articleshow/121442922.cms', snippet='India News: India is experiencing a rise in Covid-19 cases across multiple states, prompting increased vigilance from health authorities. While the numbers are re\\nWith an unwavering commitment to excellence in journalism, our team is at the forefront of gathering, verifying, and presenting breaking news, in-depth analysis, and insightful reports on a wide range of topics. The TOI News Desk is your trusted source for staying informed and connected to the ever-evolving global landscape, ensuring that our readers are equipped with the latest developments that matter most.\"Read More'), LinkupSource(name='COVID-19 Inter-Ministerial Notifications | India', url='https://covid19.india.gov.in/', snippet='Guidelines for International Arrivals (updated on 19th July 2023) · Ministry of Health and Family Welfare\\nundefined'), LinkupSource(name='Covid 19 India Cases Live Updates: 783 Covid patients recover, active cases in Delhi shrink by 37 | India News - The Indian Express', url='https://indianexpress.com/article/india/covid-19-india-active-cases-deaths-live-updates-tally-10054431/', snippet='Six Covid-19-related deaths were reported -- one each in Delhi, Kerala, Jharkhand and Maharashtra, and two Karnataka.\\nundefined'), LinkupSource(name='What is driving a surge in COVID cases in India, other countries? | Coronavirus pandemic News | Al Jazeera', url='https://www.aljazeera.com/news/2025/6/6/what-is-driving-a-surge-in-covid-cases-in-india-other-countries', snippet='All we know so far about the symptoms and spread of new COVID variant NB.1.8.1.\\nAccording to a 2023 definition by the WHO, a VUM is a variant which has undergone genetic changes that scientists believe could potentially affect the behaviour of the virus; early data suggests that this variant can grow faster or spread more easily than others, but this has not yet been confirmed.\\nThis photo illustration shows Pfizer-BioNTech COVID-19 (top) and Moderna COVID-19 vaccines [Joe Raedle//Getty Images via AFP]'), LinkupSource(name='India Situation Report', url='https://www.who.int/india/home/emergencies/coronavirus-disease-(covid-19)/india-situation-report', snippet='India Situation Reports · The WHO India Weekly COVID-19 Situational Report provides a comprehensive summary of the COVID-19 situation in India. The report provides an epidemiological overview of India, highlights WHO India operational updates on risk communication and community engagement, ...\\nIndia Situation Report 116 Coronavirus Disease (COVID-19) 22 July 2022\\nIndia Situation Report 115 Coronavirus Disease (COVID-19) 15 June 2022\\nIndia Situation Report 114 Coronavirus Disease (COVID-19) 18 May 2022\\nIndia Situation Report 113 Coronavirus Disease (COVID-19) 04 May 2022'), LinkupSource(name='India | Latest News & Updates | BBC News', url='https://www.bbc.com/news/world/asia/india', snippet='Get all the latest news, live updates and content about India from across the BBC.\\nundefined'), LinkupSource(name='COVID-19 Resurgence in 2025: A Global Health Snapshot', url='https://www.mapsofindia.com/my-india/india/covid-19-resurgence-in-2025-a-global-health-snapshot', snippet='Explore the COVID-19 resurgence in 2025 with insights into global case trends, new variants, vaccination efforts, and government responses. Stay updated.\\nBecause of all this, a new variant was found by the scientists, XEC, that was first spotted in Germany in June 2024. This group of Omicron has variations that potentially aid its spread. Though vaccines still work against major cases, these variants spreading so rapidly remind us that we have to stay cautious and update our public health approaches. To respond to new variants, creating vaccines remains a vital effort worldwide. Japan approved Zapomeran as a COVID-19 vaccine in November 2023, while the vaccine was approved in the European Union in February 2025.\\nIn 2025, as the year progresses, the pandemic is still developing. Vaccines and progress in treatments have greatly reduced the risk, but it is necessary to remain attentive, due to new variants and possible future epidemics.'), LinkupSource(name='COVID-19 lockdown in India - Wikipedia', url='https://en.wikipedia.org/wiki/COVID-19_lockdown_in_India', snippet='On the evening of 24 March 2020, the Government of India ordered a nationwide lockdown for 21 days, limiting the movement of the entire 1.38 billion (138 crores) population of India as a preventive measure against the COVID-19 pandemic in India. It was ordered after a 14-hour voluntary public ...\\nOne of the major development was around the re-opening of wine shops.'), LinkupSource(name='Highlights | COVID-19 Cases in India, New Covid-19 variants NB.1.8.1 and LF.7 Live: - India News | The Financial Express', url='https://www.financialexpress.com/india-news/covid-19-coronavirus-cases-in-india-live-updates-check-covid-19-new-variant-nb-1-8-1-lf-7-symptoms-causes-treatment-latest-news/3858402/', snippet='Covid Cases Spike in India, New Covid-19 variants NB.1.8.1 and LF.7 Detected in India Highlights: The recent rise in COVID-19 cases coincides with the detection of two new sub-variants, NB.1.8.1 and LF.7. Both are currently under observation by global health authorities due to their increased ...\\nCovid Cases Spike in India, New Covid-19 variants NB.1.8.1 and LF.7 Detected in India Highlights: The recent rise in COVID-19 cases coincides with the detection of two new sub-variants, NB.1.8.1 and LF.7. Both are currently under observation by global health authorities due to their increased transmissibility, though no significant spike in severity has been reported so far.\\nincome tax calculatorSilver rate todayGold rate todayIPOsTOCK MARKET QUOTESMutual fundsWaaree Energies IPO 2024 Live\\nDr Rao urged immunocompromised people to remain vigilant but reassured the public that the situation does not warrant alarm. The Karnataka government continues to monitor developments and issue precautionary advisories.\\nArunachal Pradesh reported its first COVID-19 case of the current wave, confirmed by the state’s Surveillance Officer, Lobsang Jampa. A 34-year-old pregnant woman tested positive via RT-PCR after initially testing positive with a Rapid Antigen Test. She developed mild symptoms and had recently arrived from Bengaluru.'), LinkupSource(name='COVID-19 in India: Four new deaths reported, active cases near 4,000 - The Hindu', url='https://www.thehindu.com/sci-tech/health/covid-19-coronavirus-cases-deaths-india-update-june-2-2025/article69647835.ece', snippet='COVID-19 in India: India reports 3,961 active COVID-19 cases, 32 deaths; government assures readiness to handle any situation.\\nMeanwhile, the World Health Organisation (WHO) noted that since mid-February 2025, global SARS-CoV-2 activity had been increasing, with the test positivity rate reaching 11%, levels that had not been observed since July 2024.'), LinkupSource(name=\"Covid cases rising, situation in India 'under control': 5 things we know about the fresh surge | Latest News India - Hindustan Times\", url='https://www.hindustantimes.com/india-news/covid-cases-rising-5-things-we-know-about-the-fresh-surge-101747655351381.html', snippet='Currently, government data shows 257 active COVID cases across various states in the country, with most of them coming from Kerala, Tamil Nadu, and Maharashtra.\\nCurrently, government data shows 257 active COVID cases across various states in the country, with most of them coming from Kerala, Tamil Nadu, and Maharashtra. | Latest News India\\nCOVID-19 variants- The JN.1 strain of COVID-19 was first found in August 2023, and the World Health Organisation (WHO) designated it as a ‘variant of interest’ in December 2023. It is a descendant of the Omicron BA.2.86 variant.\\nCurrently, the dashboard shows 257 active COVID cases across various states in the country, with most of them coming from Kerala, Tamil Nadu, and Maharashtra. Officials have urged calm, telling news agency PTI that the COVID-19 situation in India is under control.\\nMedical experts, quoted by the report, believe that the same could happen in India too. A slight spike is already visible in the country in states like Tamil Nadu, Kerala, and Maharashtra. The officials, however, told news agency PTI that the COVID-19 situation in India is under control.')]",
  "depth": "deep",
  "timestamp": "2025-07-15T00:25:02.784091",
  "metadata": {
    "query": "recent COVID-19 news and developments in South India 2023-2024",
    "depth": "deep",
    "output_type": "sourcedAnswer",
    "search_count": 3,
    "timestamp": 1752519302.784092
  },
  "from_cache": false
}